Search

… to changing lives through the creation of transformative RNA therapies for genetic eye diseases, will webcast a … its clinical stage pipeline programs and the Axiomer ® RNA editing platform. ProQR leadership will highlight key …

… to changing lives through the creation of transformative RNA therapies, today announced that Company management will … Medicines Symposium on June 29, 2022 as part of the RNA Editing track. The Company’s presentation will be webcast …

… company dedicated to changing lives through transformative RNA therapies, today announced several presentations … highlighting the Company’s proprietary Axiomer ® RNA editing technology platform at upcoming scientific and …

… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today reported its financial …

… strength of leading IP estate around ADAR-mediated RNA editing highlighted with successful defense of challenge …

… to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that … RNA therapies for genetic eye diseases and our proprietary RNA-editing platform technology.” “I first met Daniel more than a …

… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today reported its financial …